News
The Trump administration carved out an exception for pharmaceuticals from the president's new tariff regime, at least for now ...
Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...
Pharmaceutical Technology on MSN6d
FDA awards ODD status to Sanofi’s rilzabrutinib for two rare conditionsSanofi's reversible BTK inhibitor rilzabrutinib has gained the US Food and Drug Administration’s (FDA) orphan drug ...
Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies ... that the loss of experienced leadership at the FDA will erode scientific standards and broadly impact ...
Shares of Moderna, Novavax and other biotech companies fell after FDA official Peter Marks’s resignation in protest of Robert ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Medical Device Network on MSN7d
FDA approves Revvity’s Auto-Pure platform and tuberculosis test comboThe FDA has granted approval for Revvity’s Auto-Pure 2400 liquid handling platform, used in conjunction with the T-SPOT.TB ...
A surge of generics, biosimilars, and innovative therapies is expected in 2025, addressing conditions from cancer to chronic ...
Pharmaceutical Technology on MSN10d
Sanofi’s Qfitlia approved by FDA as first haemophilia therapy for all patientsDespite a haemophilia market bustling with rivals, Qfitlia’s broad label and favourable dosing regimen could give it an upper ...
The health sector faces significant instability with President Trump's tariff threats targeting Indian pharmaceutical stocks, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback